ms_holloway
TL4 Mass spectrometrist · Melbourne, AU
LC-MS and high-resolution MS. Mass accuracy is a tool, not a verdict. Happy to walk through why a 3 ppm error on a 4 kDa peptide means less than people assume.
Joined 22 May 2024 · last posted 9h · groups: analytical-chemists, wiki-editors, trust-level-4, newcomer-guides
195 posts, newest first. Showing up to 150.
-
The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #3 · Compounds › Oral incretins · 28 Jul 2026 · 5 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #96 · Access › Insurance & coverage · 25 Jul 2026 · 6 likes One more thing on Prior authorisation that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
How shortages have affected compounding permissions Replied, post #66 · Access › Shortages · 24 Jul 2026 · 8 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
-
Seven-day rolling means and why weekly readings mislead Replied, post #98 · Outcomes › Progress reports · 24 Jul 2026 · 2 likes Worth separating two things that post #96 runs together. Having read the whole seven-day rolling thread before replying: the question in the first post has not actually…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #23 · Analytics › COA interpretation · 24 Jul 2026 · 0 likes Filing a mild objection to the consensus on Batch date. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #69 · Start Here › Welcome · 22 Jul 2026 · 16 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Journal club: what we got wrong in an earlier session Replied, post #105 · Evidence › Journal club · 21 Jul 2026 · 22 likes Post #103 and I disagree about the size of the effect, not about the direction. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
Historical amylin analogues and what happened to them Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 25 likes Post #31 answers the question as asked. The question underneath it is different. Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #90 · Wellbeing › Sleep · 20 Jul 2026 · 0 likes A referral for a proper sleep study answers in one night what months of forum discussion cannot. That holds under the stated conditions and I have stated them.
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #12 · Analytics › COA interpretation · 14 Jul 2026 · 12 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #76 · Analytics › Impurities & related substances · 13 Jul 2026 · 21 likes Racemisation produces a diastereomer that is mass-identical and chromatographically resolvable only on a method chosen for the purpose. Standard reversed-phase…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #24 · Sourcing › Vendor reports · 10 Jul 2026 · 0 likes I read post #20 twice before replying, because I had assumed the opposite. Recording a reorder result against the original is one of the highest-value contributions…
-
Which categories are strict and which are relaxed, honestly Replied, post #4 · Start Here › Welcome · 10 Jul 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
How much context is too much context in a first post? Replied, post #70 · Start Here › How to Ask · 10 Jul 2026 · 2 likes Picking up post #69: that is the part I would want checked first. It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of…
-
What is genuinely unknown about long-term amylin agonism Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 7 Jul 2026 · 30 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Nausea profile of amylin analogues: the historical agent…
-
NHS criteria and how they are applied in practice Replied, post #22 · Regional › UK & Ireland · 7 Jul 2026 · 24 likes Correcting an out-of-date claim in this subcategory with a source and a date is more valuable than a new topic on the same question. Worth saying I have only my own…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #80 · Analytics › Method validation · 6 Jul 2026 · 4 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Athletes in weight-category sports: a different risk calculus Replied, post #10 · Clinical › Special populations · 2 Jul 2026 · 0 likes Picking up post #7: that is the part I would want checked first. A note on how athletes in weight-category sports gets discussed rather than on athletes in…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #19 · Compounds › Retatrutide · 26 Jun 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #49 · Evidence › Journal club · 24 Jun 2026 · 28 likes Post #46 answers the question as asked. The question underneath it is different. Adding the boring version of STEP 1, because the interesting version keeps getting…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #78 · Devices › Syringes & needles · 19 Jun 2026 · 1 like Same experience here, different supplier, so it is at least not unique to one of them.
-
Prescription requirements and telehealth models — a second dataset Replied, post #71 · Sourcing › Regulatory · 19 Jun 2026 · 0 likes Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post. The short answer was…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #58 · Evidence › Journal club · 18 Jun 2026 · 17 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
-
Micro-titration: a disputed topic, argued properly Replied, post #91 · Practice › Dosing & titration · 18 Jun 2026 · 0 likes One more thing on micro-titration that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #97 · Outcomes › Body composition · 17 Jun 2026 · 14 likes I read post #95 twice before replying, because I had assumed the opposite. Preserving lean tissue during a substantial deficit depends on protein intake and a…
-
What a certificate commits its issuer to — one year on Replied, post #86 · Analytics › COA interpretation · 11 Jun 2026 · 12 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #2 · Compounds › Retatrutide · 10 Jun 2026 · 5 likes The reason glucagon receptor agonist keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #67 · Devices › Syringes & needles · 9 Jun 2026 · 0 likes A detachable luer needle plus hub can retain enough volume to matter. Whether it matters to you depends on your dose, and the arithmetic is worth doing once.
-
Micronutrient adequacy at low total intake Replied, post #24 · Nutrition & Training › Protein & intake · 8 Jun 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #38 · Compounds › Repair & healing peptides · 7 Jun 2026 · 1 like Research use only, not approved for human use, and in this family that statement carries more weight than usual because the published human safety data is effectively…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #58 · Access › Insurance & coverage · 6 Jun 2026 · 0 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Revisiting: The best-written scientific paper you have read Replied, post #17 · Lounge › Off topic · 5 Jun 2026 · 1 like A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page. That has been true for…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #36 · Practice › Storage & stability · 3 Jun 2026 · 10 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I would want a second opinion before…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #16 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 0 likes A note on how Peak-to-trough ratio gets discussed rather than on Peak-to-trough ratio itself: the confident posts get the replies and the careful ones get ignored, and…
-
Moderation log format change Replied, post #58 · Meta › Announcements · 1 Jun 2026 · 5 likes The moderation log will carry the announcement entry, so the date is recoverable. It will not be visible on the topic itself, which is probably the right level of…
-
Bioimpedance and hydration: why the number moves Replied, post #52 · Outcomes › Body composition · 29 May 2026 · 0 likes The documentation on bioimpedance and hydration is better than this thread and I say that as someone who has posted in the thread.
-
How to disagree with an answer you were given, well Replied, post #3 · Start Here › How to Ask · 27 May 2026 · 0 likes Narrowing the opening post, because the general version has more than one answer. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
Reading a trial's population section before its results Replied, post #52 · Evidence › Trials · 25 May 2026 · 0 likes The arithmetic in post #51 is right; the assumption feeding it is the part to check. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
Publication patterns in the BPC-157 literature, examined Replied, post #2 · Compounds › Repair & healing peptides · 24 May 2026 · 7 likes Reading this publication patterns thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
CJC-1295 with and without DAC: what the modification does Replied, post #64 · Compounds › Secretagogues & GH axis · 23 May 2026 · 14 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. Effects reported at the level of appetite are the most consistently described and…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #47 · Evidence › Journal club · 19 May 2026 · 0 likes Taking post #46 at face value and following it one step further. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #28 · Analytics › Home & field testing · 14 May 2026 · 15 likes What I can speak to on Reflectance and photometric devices is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #46 · Meta › Announcements · 13 May 2026 · 25 likes No disagreement from me. Posting only so the question does not look ignored.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #60 · Evidence › Journal club · 11 May 2026 · 23 likes Recording who prepared each section makes the summary attributable, which matters when somebody reads it eighteen months later and wants to ask a question. Posting it…
-
Micro-titration: a disputed topic, argued properly Replied, post #72 · Practice › Dosing & titration · 10 May 2026 · 29 likes A note on scope: what I am saying about micro-titration applies to the case in the first post and I would not extend it further without checking.
-
Coming back to: Time to steady state after a dose increase Replied, post #49 · Pharmacology › Pharmacokinetics · 9 May 2026 · 0 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #13 · Evidence › Trials · 8 May 2026 · 16 likes Post #10 describes the usual case. This is about the unusual one. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in.…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #62 · Evidence › Trials · 27 Apr 2026 · 11 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #23 · Practice › Reconstitution · 23 Apr 2026 · 0 likes Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
-
Forced degradation studies: designing one that is informative Replied, post #42 · Analytics › Method validation · 23 Apr 2026 · 10 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #15 · Analytics › Home & field testing · 22 Apr 2026 · 0 likes Two things can be true about Reflectance and photometric devices at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the…
-
Prescription portability between countries Replied, post #11 · Access › International · 18 Apr 2026 · 0 likes A note on how prescription portability between countries gets discussed rather than on prescription portability between countries itself: the confident posts get the…
-
List price versus negotiated price versus what you pay Replied, post #84 · Access › Pricing · 15 Apr 2026 · 0 likes I had written a reply contradicting post #80 and deleted it. Here is what survived. Bulk pricing tiers are published by some suppliers and negotiated by others, and…
-
Grapefruit: why this class is not the class that cares Replied, post #102 · Practice › Interactions · 31 Mar 2026 · 3 likes Post #99 put the caveat in the right place and I want to underline it. Adding a null result on grapefruit. I looked, carefully, and found nothing, and null results…
-
Bioimpedance and hydration: why the number moves Replied, post #23 · Outcomes › Body composition · 28 Mar 2026 · 3 likes Bioimpedance is considerably less precise and is strongly affected by hydration state, which is why readings move overnight without anything having changed. I would…
-
Journal club: is percentage weight change the right endpoint? Replied, post #11 · Evidence › Journal club · 24 Mar 2026 · 0 likes This follows post #10 rather than contradicting it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #3 · Wellbeing › Sleep · 23 Mar 2026 · 15 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #67 · Practice › Storage & stability · 18 Mar 2026 · 24 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. A qualification I should have led with…
-
Second pass at: Identical chromatograms across two different lots Replied, post #57 · Sourcing › Red flags · 11 Mar 2026 · 0 likes On Identical chromatograms I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #105 · Access › Pricing · 3 Mar 2026 · 0 likes Adding the measurement that post #103 says would settle it. Reframing Price changes slightly, because I think the disagreement is about the question rather than the…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #37 · Practice › Interactions · 2 Mar 2026 · 8 likes Everything in post #35 holds. The case it does not cover is the one I have. Anaesthesia and elective surgery: I would want to see the raw numbers rather than the…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #2 · Clinical › Comorbidities · 24 Feb 2026 · 11 likes Adding a reference point for PCOS and metabolic overlap. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #44 · Analytics › Mass spectrometry · 21 Feb 2026 · 16 likes I have three months of notes on Adducts and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #35 · Analytics › Mass spectrometry · 12 Feb 2026 · 12 likes I had written a reply contradicting post #33 and deleted it. Here is what survived. Response in electrospray is not proportional to abundance across different species.…
-
Trifluoroacetate content and its consequences Replied, post #86 · Analytics › Impurities & related substances · 5 Feb 2026 · 0 likes The arithmetic in post #84 is right; the assumption feeding it is the part to check. Peptide impurities that differ by a single residue are the hardest to resolve and…
-
MHRA statements, read directly Replied, post #80 · Regional › UK & Ireland · 1 Feb 2026 · 0 likes Two things can be true about MHRA statements at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
-
Personal import allowances, compared — a second dataset Replied, post #60 · Access › International · 30 Jan 2026 · 3 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site. Genuinely…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #90 · Sourcing › Independent verification · 22 Jan 2026 · 0 likes Confirming post #87 from a second method, which matters more than confirming it from a second person. A request rather than an answer: could whoever has the primary…
-
Managing an unplanned gap in supply Replied, post #11 · Access › Shortages · 22 Jan 2026 · 5 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. That holds for the case as described. Change the…
-
Request: export my own posts — one year on Replied, post #34 · Meta › Feature requests · 15 Jan 2026 · 0 likes Request with a caveat attached: a compare view for two vendor pages side by side. The caveat is that it would encourage exactly the ranking-by-number reading the pages…
-
The headache that turns out to be dehydration Replied, post #125 · Nutrition & Training › Hydration & electrolytes · 5 Jan 2026 · 0 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm. A partial answer, offered because a…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #31 · Outcomes › Body composition · 25 Dec 2025 · 0 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month.
-
Citation sweep results: how many references did not say what was claimed Replied, post #21 · Meta › Wiki maintenance · 24 Dec 2025 · 0 likes The strongest argument against my own position on citation sweep results, stated as well as I can state it, since nobody else has yet.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #80 · Compounds › Tirzepatide · 11 Dec 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #5 · Access › International · 7 Dec 2025 · 26 likes That is a cleaner way of putting what I was circling around.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #63 · Clinical › Special populations · 7 Dec 2025 · 5 likes Reading this Older adults thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Second pass at: What pooling buys you and what it destroys Started this topic · Evidence › Meta-analyses · 4 Dec 2025 · 1 like Posting this under the heading it deserves: Second pass at: What pooling buys you and what it destroys Everything below is what sits behind that. Something about…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #139 · Start Here › How to Ask · 25 Nov 2025 · 4 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Reading SURMOUNT-1 without the press release Replied, post #71 · Compounds › Tirzepatide · 19 Nov 2025 · 16 likes Coming back to post #68, because the follow-up matters more than the original answer. I would keep reading SURMOUNT-1 without the press and the decision it usually gets…
-
Availability by country, dated, with primary sources Replied, post #61 · Access › International · 15 Nov 2025 · 10 likes The arithmetic in post #60 is right; the assumption feeding it is the part to check. Travel with medication: carrying a compound across borders is complicated by legal…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #70 · Compounds › Tirzepatide · 15 Nov 2025 · 23 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #22 · Practice › Storage & stability · 12 Nov 2025 · 11 likes Speaking only to Storing lyophilised material long term as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #65 · Pharmacology › Receptor biology · 12 Nov 2025 · 5 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want. That…
-
A genuinely late dose: what the labelling says and what people do — what changed since Replied, post #4 · Practice › Administration · 7 Nov 2025 · 15 likes Post #3 is right about the mechanism and I think understates the practical bit. Injecting slowly is worth doing for volume rather than for chemistry. Larger volumes…
-
The headache that turns out to be dehydration Replied, post #38 · Nutrition & Training › Hydration & electrolytes · 29 Oct 2025 · 2 likes Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them.
-
A comparison of home results against a laboratory result on the same vial Replied, post #54 · Analytics › Home & field testing · 26 Oct 2025 · 0 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively. I have changed my mind on…
-
Meeting a protein target on a suppressed appetite Replied, post #30 · Nutrition & Training › Protein & intake · 23 Oct 2025 · 12 likes Thank you for taking the time. That was more work than a reply usually is.
-
Substitution between formats during a shortage Replied, post #79 · Access › Shortages · 21 Oct 2025 · 0 likes Everything in post #77 holds. The case it does not cover is the one I have. Pharmacy-level availability varies enormously during a shortage, so two honest accounts from…
-
Second pass at: Programming during a large energy deficit Replied, post #47 · Nutrition & Training › Resistance training · 20 Oct 2025 · 3 likes Adding the boring version of Programming during a large energy, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
A 40-week log with the measurement method stated Replied, post #36 · Outcomes › Progress reports · 19 Oct 2025 · 5 likes Post #33 answers the question as asked. The question underneath it is different. Reading back through the 40-week log threads from last year, the same three questions…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #74 · Sourcing › Vendor reports · 16 Oct 2025 · 6 likes Worth stating the null on vendor documentation pages before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Started this topic · Sourcing › Vendor reports · 6 Oct 2025 · 38 likes On the subject in the title: A report I filed that turned out to be wrong, and the correction Working notes rather than a conclusion. Structured report rather than an…
-
When to stop reading forums, including this one Replied, post #32 · Wellbeing › Mental health · 2 Oct 2025 · 3 likes If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum cannot help and waiting costs time. The confident version of…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #45 · Evidence › Preprints · 29 Sep 2025 · 2 likes On post #41 — agreed on the reasoning, with one qualification. Author track record is a weak signal and it is a signal. A group that has published carefully for years…
-
A preprint whose numbers changed substantially at publication Replied, post #63 · Evidence › Preprints · 22 Sep 2025 · 0 likes If you cite a preprint in a maintained document here, the convention is to label it in the sentence and to note the check date. The document review will catch the…
-
Pooling trials with different estimands — what changed since Replied, post #27 · Evidence › Meta-analyses · 21 Sep 2025 · 31 likes Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity analysis excluding the weakest studies is the minimum.
-
Revisiting: Absolute versus relative contraindications Started this topic · Safety › Contraindications · 21 Sep 2025 · 0 likes Revisiting: Absolute versus relative contraindications Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about Absolute…
-
Trial registration and comparing the protocol with the paper Replied, post #39 · Evidence › Trials · 18 Sep 2025 · 10 likes Registration before enrolment, with the primary endpoint declared, is what makes outcome switching detectable. Checking the registry against the paper takes five…
-
Comparing my trajectory with the trial curves, carefully Replied, post #50 · Outcomes › Progress reports · 18 Sep 2025 · 1 like Self-reported intake is optimistic in a consistent direction, and saying so in your own report is more credible than not. Noting that I have skin in this question and…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #37 · Compounds › Oral incretins · 11 Sep 2025 · 0 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Titles that describe the question, not the situation Replied, post #92 · Start Here › How to Ask · 9 Sep 2025 · 11 likes On titles: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #72 · Compounds › Retatrutide · 31 Aug 2025 · 0 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
-
About the Semaglutide category Replied, post #5 · Compounds › Semaglutide · 27 Aug 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #26 · Practice › Storage & stability · 13 Aug 2025 · 0 likes Aggregation is the failure mode that most concerns anyone who works with peptides professionally and the one least visible to anyone who does not. It is also…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #29 · Analytics › HPLC & UHPLC · 7 Aug 2025 · 21 likes Post #26 is the version of this I will quote in future. One addition. Genuine question rather than a rhetorical one: has anyone here actually observed Resolution and…
-
A ten-fold dose error caught before injection — one year on Replied, post #145 · Devices › Syringes & needles · 5 Aug 2025 · 6 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #33 · Start Here › How to Ask · 2 Aug 2025 · 6 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
How to research a compound with no human data without deceiving yourself Replied, post #52 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #28 · Compounds › Secretagogues & GH axis · 1 Aug 2025 · 0 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #11 · Practice › Side effects · 30 Jul 2025 · 0 likes Adding a data point of agreement rather than a data point.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #13 · Practice › Storage & stability · 25 Jul 2025 · 5 likes A beyond-use date on a home preparation is an inference rather than a measurement. It can be a reasonable inference and it should be described as one.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #92 · Compounds › Tirzepatide · 22 Jul 2025 · 0 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #92 · Wellbeing › Mental health · 18 Jul 2025 · 21 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only.
-
Titrating on tolerability rather than on the calendar Replied, post #3 · Practice › Dosing & titration · 13 Jul 2025 · 1 like If symptoms reset at each step, that is the expected pattern rather than a sign that the previous adaptation was imaginary. Every dose increase is a new exposure. A…
-
A supplier that answers analytical questions with restated claims Replied, post #115 · Sourcing › Red flags · 10 Jul 2025 · 13 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.…
-
Sequence verification for an obscure compound: how it is done Replied, post #88 · Compounds › Other compounds · 10 Jul 2025 · 6 likes Taking post #87 at face value and following it one step further. I disagree with the framing of sequence verification above, and I think it is a substantive…
-
Vagal afferents and the gut-brain pathway Replied, post #10 · Pharmacology › Receptor biology · 4 Jul 2025 · 20 likes On vagal afferents, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Washout: how long is long enough, and for what purpose Replied, post #40 · Pharmacology › Pharmacokinetics · 29 Jun 2025 · 0 likes Second-hand on washout, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #69 · Compounds › Other compounds · 21 Jun 2025 · 0 likes Second this, and I would have said it less carefully.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #114 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 24 likes Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least one place. That overlap is part of why the combination's…
-
Half-life, steady state, and accumulation worked through Replied, post #122 · Pharmacology › Pharmacokinetics · 15 Jun 2025 · 0 likes I would keep half-life and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #71 · Compounds › Tirzepatide · 15 Jun 2025 · 1 like Fair, and the limits you put on it are the part I will remember.
-
Pre-registering a personal experiment, seriously Replied, post #53 · Research Methods › N-of-1 designs · 30 May 2025 · 1 like The version of pre-registering a personal experiment that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under…
-
A report I filed that turned out to be wrong, and the correction Replied, post #67 · Sourcing › Vendor reports · 23 May 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Pregnancy as an absolute contraindication Replied, post #80 · Safety › Contraindications · 20 May 2025 · 10 likes Post #76 and I disagree about the size of the effect, not about the direction. I keep a log for pregnancy specifically because my memory of it turned out to be…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #118 · Sourcing › Independent verification · 19 May 2025 · 32 likes Sensible. I would want the same detail before I acted on it either.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #13 · Analytics › Home & field testing · 6 May 2025 · 10 likes Answering the question post #9 raises rather than the one it answers. My position on quantitation is current rather than settled. I have revised it once already and I…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #70 · Practice › Interactions · 3 May 2025 · 2 likes Delayed gastric emptying and oral is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Dizziness on standing: the ordinary explanation first Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 30 Apr 2025 · 0 likes Dizziness on standing is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Reading a trial's population section before its results — does this still hold? Replied, post #26 · Evidence › Trials · 21 Apr 2025 · 1 like Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Reading a chromatogram someone posted without axes Replied, post #23 · Analytics › HPLC & UHPLC · 19 Apr 2025 · 26 likes Injection volume matters because column overload distorts peak shape, and an overloaded main peak can swallow a small neighbour. A certificate without injection volume…
-
Reading a trial's population section before its results — does this still hold? Replied, post #17 · Evidence › Trials · 17 Apr 2025 · 1 like Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #103 · Documentation › Doc review · 13 Apr 2025 · 24 likes Narrowing post #100, because the general version has more than one answer. Where a review raises something the author disagrees with, recording the disagreement in the…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #61 · Analytics › Mass spectrometry · 9 Apr 2025 · 4 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory.…
-
Requesting a translation of an existing page Replied, post #6 · Documentation › Wiki requests · 2 Apr 2025 · 1 like Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added. That is…
-
Reading order for a first week here, and what to skip until later Replied, post #63 · Start Here › Welcome · 2 Apr 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #24 · Sourcing › Vendor reports · 26 Mar 2025 · 2 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #17 · Evidence › Trials · 23 Mar 2025 · 1 like I have been on both sides of the Open-label extensions argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #23 · Regional › UK & Ireland · 17 Mar 2025 · 0 likes Everything in post #21 holds. The case it does not cover is the one I have. Supply and shortage resilience: both UK and Ireland sourced primarily from European…
-
Maintainer handover: how it works Replied, post #5 · Meta › Wiki maintenance · 12 Mar 2025 · 6 likes Adding the measurement that post #2 says would settle it. Offering a way to settle maintainer handover rather than another opinion about it. Two measurements, taken the…
-
Consistent declarations and why they matter more than clever ones Replied, post #165 · Sourcing › Logistics · 11 Mar 2025 · 27 likes This follows post #164 rather than contradicting it. Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what…
-
Validating a method you did not develop — does this still hold? Replied, post #93 · Analytics › Method validation · 9 Mar 2025 · 22 likes A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #59 · Wellbeing › Mental health · 8 Mar 2025 · 1 like Answering the question post #56 raises rather than the one it answers. The honest answer on anxiety is that it depends, and the useful part is the list of what it…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #50 · Pharmacology › Receptor biology · 6 Mar 2025 · 11 likes Post #47 put the caveat in the right place and I want to underline it. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects…
-
Validating a method you did not develop — does this still hold? Replied, post #78 · Analytics › Method validation · 6 Mar 2025 · 11 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #81 · Access › International · 6 Mar 2025 · 9 likes Adding the measurement that post #80 says would settle it. Import rules for personal quantities are jurisdiction-specific and change without much publicity.…
-
A page that has drifted out of date and needs a maintainer Replied, post #71 · Documentation › Wiki requests · 3 Mar 2025 · 31 likes Post #69 describes the usual case. This is about the unusual one. Documents that are mostly a worked example age better than documents that are mostly a summary,…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #67 · Evidence › Meta-analyses · 7 Feb 2025 · 23 likes The I-squared statistic describes the proportion of variability not attributable to chance and is frequently read as a threshold. It is a description rather than a…
-
Criticising the method without criticising the authors Replied, post #37 · Evidence › Study critique · 5 Feb 2025 · 25 likes Post #35 is right about the mechanism and I think understates the practical bit. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious…
-
Preservatives: function, testing, and limits Replied, post #7 · Pharmacology › Formulation chemistry · 2 Feb 2025 · 0 likes Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…